HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SAI Lab Director ‘Elated’ By Federal Talc-Asbestos Testing Recs: ‘We Need To Be Aware That It’s There’

Executive Summary

State-of-the-art testing approaches increasingly show that asbestos contamination of cosmetic talc is a concern worthy of the renewed attention it is receiving from federal agencies, says Scientific Analytical Institute’s research director Sean Fitzgerald.

You may also be interested in...



CIR Expert Panel Tentatively OKs Silicate Ingredients With Crystalline Caveats; Full Meeting Results

The Cosmetic Ingredient Review’s Expert Panel for Cosmetic Ingredient Safety issued seven final assessments, six tentative reports and two insufficient data announcements at its virtual meeting on March 11-12.

FDA Clarification: Interagency Recommendations On Talc-Asbestos Test Methods Not Formal Guidance

The Executive Summary of an interagency working group's preliminary recommendations on testing methods for asbestos in talc and talc-containing consumer products, released by the FDA in early 2020, does not constitute a formal position taken by the FDA, it says, noting that concerns have arisen recently about misunderstanding among "external parties."

J&J’s Baby Powder Announcement Renews NGO Calls For Industry, FDA To End Use Of Talc In Cosmetics

The Environmental Working Group and US PIRG suggest that beauty and personal-care firms should avoid using talc in loose powders, if not all cosmetic products, and that the US FDA should consider banning the ingredient due to the potential for asbestos contamination, among other concerns.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS149768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel